E-LIB Suche - Ergebnisse für: Zvirbule, Z.

1

244MO Primary results from IMscin002: A study to evaluate p..:

Cappuzzo, F. ; Zvirbule, Z. ; Korbenfeld, E.P....
ESMO Open. 9 (2024) - p. 102706 , 2024

Link: https://doi.org/10.1016/..

2

IMscin001 Part 2: a randomised phase III, open-label, multi..:

Burotto, M. ; Zvirbule, Z. ; Mochalova, A....
Annals of Oncology. 34 (2023) 8 - p. 693-702 , 2023

Link: https://doi.org/10.1016/..

3

61MO IMscin001 (part 2: randomized phase III): Pharmacokine..:

Burotto, M. ; Zvirbule, Z. ; Mochalova, A....
Immuno-Oncology and Technology. 16 (2022) - p. 100166 , 2022

Link: https://doi.org/10.1016/..

4

A phase II randomized trial of cobimetinib plus chemotherap..:

Brufsky, A. ; Kim, S.B. ; Zvirbule, Ž....
Annals of Oncology. 32 (2021) 5 - p. 652-660 , 2021

Link: https://doi.org/10.1016/..

5

A multicentre, phase IIa study of zolbetuximab as a single ..:

Türeci, O. ; Sahin, U. ; Schulze-Bergkamen, H....
Annals of Oncology. 30 (2019) 9 - p. 1487-1495 , 2019

Link: https://doi.org/10.1093/..

6

1800 Final results for overall survival (OS), the primary e..:

Zielinski, C.C. ; Lang, I. ; Inbar, M....
European Journal of Cancer. 51 (2015) - p. S263-S264 , 2015

Link: https://doi.org/10.1016/..

7

IFOSFAMIDUM AS PALLIATIVE TREATMENT FOR ADVANCED OVARIAN CA..:

Plate, S. ; Zvirbule, Z. ; Kasperova, S.
International Journal of Gynecologic Cancer. 25 (2015) Supp 1 - p. 59-59 , 2015

Link: https://doi.org/10.1136/..

8

2702 Safety and efficacy in ROSiA, a single-arm study of ex..:

Oza, A.M. ; Selle, F. ; Davidenko, I....
European Journal of Cancer. 51 (2015) - p. S532 , 2015

Link: https://doi.org/10.1016/..

9

2731 Impact of frailty on outcome of elderly patients treat..:

Joly, F. ; Pautier, P. ; Vergote, I....
European Journal of Cancer. 51 (2015) - p. S541 , 2015

Link: https://doi.org/10.1016/..

10

Efficacy and Safety Results From a Phase 2, Placebo-Control..:

Hirsch, F.R. ; Govindan, R. ; Zvirbule, Z....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S37 , 2014

Link: https://doi.org/10.1016/..

11

Efficacy and Safety of Onartuzumab in Combination With Firs..:

Wakelee, H.A. ; Zvirbule, Z. ; De Braud, F....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S37-S38 , 2014

Link: https://doi.org/10.1016/..

12

Safety results from a phase III study (TURANDOT trial by CE..:

Lang, I. ; Inbar, M.J. ; Kahán, Z....
European Journal of Cancer. 48 (2012) 17 - p. 3140-3149 , 2012

Link: https://doi.org/10.1016/..

13

5053 POSTER Randomized Phase III Study of First-line Bevaci..:

Inbar, M. ; Lang, I. ; Kahán, Z....
European Journal of Cancer. 47 (2011) - p. S346 , 2011

Link: https://doi.org/10.1016/..

14

5058 Bevacizumab (Bev) combined with either capecitabine (X..:

Lang, I. ; Inbar, M. ; Steger, G....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 277-278 , 2009

Link: https://doi.org/10.1016/..

15

Case Report: Epstein-Barr virus Positive Gastric Carcinoma:

E, Gasenko ; A, Hegmane ; S, Plate...
Integrative Gastroenterology and Hepatology. , 2019

Link: https://doi.org/10.18314..